We are live on ! Find out more
GIM

Granahan Investment Management Portfolio holdings

AUM $2.07B
1-Year Est. Return 56.45%
This Fund
S&P 500
This Quarter Est. Return
-19.73%
1 Year Est. Return
+56.45%
3 Year Est. Return
+154.74%
5 Year Est. Return
+144.99%
10 Year Est. Return
+2,522.93%
AUM
$1.41B
AUM Growth
-$431M
Cap. Flow
-$49.9M
Cap. Flow %
-3.54%
Top 10 Hldgs %
24.85%
Holding
216
New
15
Increased
64
Reduced
101
Closed
23

Top Buys

Rank Stock Value
1
PCTY icon
Paylocity
PCTY
+$13.6M
2
AZTA icon
Azenta
AZTA
+$12.2M
3
COUP
Coupa Software Incorporated
COUP
+$11.4M
4
JBTM
JBT Marel
JBTM
+$11.4M
5
WW
WW International
WW
+$11.1M

Top Sells

Rank Stock Value
1
SODA
SodaStream International Ltd
SODA
+$42.2M
2
MB
MINDBODY, Inc. Class A Common Stock
MB
+$13.7M
3
STRA icon
Strategic Education
STRA
+$12.1M
4
EVBG
Everbridge, Inc. Common Stock
EVBG
+$11.4M
5
EBIX
Ebix Inc
EBIX
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 34.67%
2 Healthcare 21.97%
3 Industrials 15.66%
4 Consumer Discretionary 8.08%
5 Consumer Staples 4.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ANGI icon
176
Angi Inc
ANGI
$196M
$562K 0.04%
3,498
+501
+17% +$90.8K
LYV icon
177
Live Nation Entertainment
LYV
$42.1B
$516K 0.04%
10,476
-10,699
-51% -$565K
AXGN icon
178
Axogen
AXGN
$2.5B
$471K 0.03%
+23,050
New +$721K
JNCE
179
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$443K 0.03%
131,393
-3,887
-3% -$18.2K
MGNI icon
180
Magnite
MGNI
$3.55B
$354K 0.03%
+94,790
New +$362K
NBRV
181
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$354K 0.03%
970
-19
-2% -$10.2K
FBRX icon
182
Forte Biosciences
FBRX
$1.57B
$342K 0.02%
111
-2
-2% -$8.61K
VST icon
183
Vistra
VST
$47.4B
$329K 0.02%
14,366
-49,729
-78% -$1.17M
ENPH icon
184
Enphase Energy
ENPH
$5.53B
$285K 0.02%
+60,254
New +$306K
KA
185
DELISTED
Kineta, Inc. Common Stock
KA
$260K 0.02%
573
-12
-2% -$8.13K
HAE icon
186
Haemonetics
HAE
$4B
$255K 0.02%
2,550
– –
MLNT
187
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$247K 0.02%
62,199
-1,113
-2% -$14.2K
MGPI icon
188
MGP Ingredients
MGPI
$375M
$239K 0.02%
+4,181
New +$282K
IONS icon
189
Ionis Pharmaceuticals
IONS
$9.4B
$233K 0.02%
4,316
– –
EPAY
190
DELISTED
Bottomline Technologies Inc
EPAY
$211K 0.01%
4,400
– –
FCFS icon
191
FirstCash
FCFS
$8.78B
$203K 0.01%
2,810
– –
NEOG icon
192
Neogen
NEOG
$2.5B
$201K 0.01%
7,066
– –
VYNT
193
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$66K ﹤0.01%
1,819
-36
-2% -$3.04K
BOX icon
194
Box
BOX
$4.6B
– –
-351,319
Closed -$8.4M
CCOI icon
195
Cogent Communications
CCOI
$508M
– –
-41,612
Closed -$2.32M
CVGW
196
DELISTED
Calavo Growers
CVGW
– –
-3,169
Closed -$306K
FLGT icon
197
Fulgent Genetics
FLGT
$527M
– –
-227,509
Closed -$894K
FRPT icon
198
Freshpet
FRPT
$3.22B
– –
-132,077
Closed -$4.85M
HQY icon
199
HealthEquity
HQY
$8.75B
– –
-2,580
Closed -$244K
PEGA icon
200
Pegasystems
PEGA
$5.38B
– –
-7,540
Closed -$236K
5 6 7
8
9

Similar funds

HBT
Hills Bank & Trust North Liberty, Iowa $2.07B AUM 13.46% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
SW
SoFi Wealth San Francisco, California $2.08B AUM 18.22% 1-Year Est. Return
WFMPM
Woodley Farra Manion Portfolio Management Indianapolis, Indiana $2.05B AUM 14.54% 1-Year Est. Return
AG
Avala Global New York $2.08B AUM 87.66% 1-Year Est. Return
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return

Granahan Investment Management's Q4 2018 Portfolio in Review

As of Q4 2018, Granahan Investment Management held 216 positions worth $1.41B, down 23% from $1.84B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Granahan Investment Management withdrew a net $49.9M in Q4 2018, closing 23 positions and reducing 101 holdings. Its most notable exit was SodaStream International Ltd, an estimated $42.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 33% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Granahan Investment Management opened a new position in JBT Marel worth $9.22M.

  • Granahan Investment Management's largest Q4 2018 buy was JBT Marel: 128,350 shares worth $9.22M.
  • Granahan Investment Management added most to Paylocity in Q4 2018, an estimated $13.6M increase.
  • Granahan Investment Management's biggest Q4 2018 reduction was Strategic Education, cutting an estimated $12.1M.
  • Granahan Investment Management fully exited SodaStream International Ltd in Q4 2018, selling an estimated $42.2M.
  • Granahan Investment Management's ten largest holdings make up 25% of its $1.41B portfolio in Q4 2018.
  • Granahan Investment Management opened 15 new positions and closed 23 in Q4 2018.
  • Granahan Investment Management's portfolio value fell 23% quarter-over-quarter to $1.41B.

Based on Granahan Investment Management's 13F filing for Q4 2018, filed 13 Feb 2019.